Leukapheresis Device Market Outlook Assessing Future Opportunities And Growth Prospects

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Leukapheresis Device Market Through 2030?

The leukapheresis device market has experienced substantial growth in recent years. It is anticipated to expand from $0.7 billion in 2025 to $0.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. This historical growth can be ascribed to the increasing occurrence of leukemia and autoimmune disorders, the uptake of stem cell therapies, improvements in blood cell separation technology, an increase in clinical research activities, and the development of hospital-based apheresis services.

The leukapheresis device market is projected to experience robust expansion over the coming years. This market is forecast to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. The anticipated growth during this period can be attributed to the rising demand for portable leukapheresis systems, the incorporation of ai and automation into devices, the expansion of biopharmaceutical research, the granting of regulatory approvals for advanced apheresis devices, and increasing investments in precision medicine. Significant trends in the forecast period include the development of personalized leukapheresis treatments, the adoption of minimally invasive apheresis techniques, the availability of portable and point-of-care leukapheresis devices, the integration of real-time monitoring systems, and enhanced automation and workflow efficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Which Significant Factors Are Encouraging Growth In The Leukapheresis Device Market?

An anticipated increase in blood-related disorders is set to boost the expansion of the leukapheresis device market in the coming years. These disorders involve conditions that affect the structural integrity or functional capability of blood cells, leading to issues with oxygen transport, the body’s immune defense, or blood coagulation. The growing occurrence of such conditions is predominantly linked to an aging global population, given that older individuals exhibit higher susceptibility to ailments like anemia, leukemia, and other hematological issues. Leukapheresis devices play a role in managing these conditions by facilitating the targeted removal of surplus or atypical white blood cells from the circulation, which in turn helps to ease symptoms and diminish complications in diseases like leukemia and various autoimmune disorders. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that approximately 19,500 Australians received a diagnosis of blood cancer, encompassing leukemia, lymphoma, and myeloma. Notably, nearly 43% faced significant out-of-pocket treatment costs, and 42% were absent from work for more than three months, which underscores both the increasing incidence and the financial burden on patients and their families compared to previous years. Consequently, the increasing prevalence of blood-related disorders is indeed fueling the expansion of the leukapheresis device market.

What Segment Types Are Included In The Leukapheresis Device Market Analysis?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

Which Trends Are Guiding The Development Of The Leukapheresis Device Market?

Leading companies operating within the leukapheresis device market are prioritizing investments in establishing regional manufacturing capabilities. This focus aims to enhance the availability of premium therapeutic devices locally and to further national healthcare objectives. Such regional production endeavors foster streamlined and adaptable supply chains, which in turn guarantee prompt product delivery, lessen reliance on imported goods, and make advanced blood and cell collection systems more economically accessible. A notable example occurred in November 2024, when Terumo Blood and Cell Technologies, a medical technology firm based in the US, collaborated with its China-based medical technology subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to commence local production activities in Hangzhou, China. This calculated initiative involves the domestic creation of key leukapheresis items, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are extensively utilized throughout China for therapeutic apheresis, stem cell collection, and the separation of blood components.

Who Are The Key Market Participants In The Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

Access The Complete Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Region Has The Strongest Presence In The Leukapheresis Device Market?

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Leukapheresis Device Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Electrical Stimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795